✦ LIBER ✦

(R)-Sila-venlafaxine: A Selective Noradrenaline Reuptake Inhibitor for the Treatment of Emesis.

✍ Scribed by Graham A. Showell; Matthew J. Barnes; Juergen O. Daiss; John S. Mills; John G. Montana; Reinhold Tacke; Julie B. H. Warneck

Publisher: John Wiley and Sons
Year: 2006
Weight: 21 KB
Volume: 37
Category: Article
ISSN: 0931-7597
DOI: 10.1002/chin.200631157

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sila-venlafaxine, a Sila-Analogue of the

Sila-venlafaxine, a Sila-Analogue of the Serotonin/Noradrenaline Reuptake Inhibitor Venlafaxine: Synthesis, Crystal Structure Analysis, and Pharmacological Characterization.

✍ Juergen O. Daiss; Christian Burschka; John S. Mills; John G. Montana; Graham A. 📂 Article 📅 2006 🏛 John Wiley and Sons ⚖ 11 KB

Milnacipran: The Clinical Properties of

Milnacipran: The Clinical Properties of a Selective Serotonin and Noradrenaline Reuptake Inhibitor (SNRI)

✍ Y. Lecrubier 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 134 KB 👁 2 views

Milnacipran is a novel antidepressant agent which selectively inhibits the reuptake of serotonin and noradrenaline without directly aecting postsynaptic receptor sites. The biochemical and pharmacological pro®le of milnacipran suggested that the drug would be therapeutically eective and well tolerat

ChemInform Abstract: Synthesis of a Pote

ChemInform Abstract: Synthesis of a Potent Wide-Spectrum Serotonin-, Norepinephrine-, Dopamine-Reuptake Inhibitor (SNDRI) and a Species-Selective Dopamine-Reuptake Inhibitor Based on the Gamma-Amino Alcohol Functional Group.

✍ P. R. CARLIER; M. M.-C. LO; P. C.-K. LO; E. RICHELSON; M. TATSUMI; I. J. REYNOLD 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 31 KB 👁 2 views

ChemInform Abstract: Advances in Develop

ChemInform Abstract: Advances in Development of Methods for the Synthesis of Dual Selective Serotonin and Norepinephrine Reuptake Inhibitors (SSNRIs) [Venlafaxine Hydrochloride (Effexor), Milnacipran Hydrochloride (Ixel, Dalcipran) and Duloxetine Hydrochloride (Cymbalta)]

✍ Marta Pineiro-Nunez 📂 Article 📅 2009 🏛 John Wiley and Sons ⚖ 15 KB 👁 1 views

ChemInform Abstract: The Asymmetric Synt

ChemInform Abstract: The Asymmetric Synthesis of Sitagliptin, a Selective Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes.

✍ Feng Liu; Wansheng Yu; Wenhua Ou; Xiaoke Wang; Libo Ruan; Yiming Li; Xijiang Pen 📂 Article 📅 2010 🏛 John Wiley and Sons ⚖ 23 KB 👁 1 views

## Abstract Key step in the improved synthetic pathway to sitagliptin (VII), a new DPP‐IV inhibitor for the treatment of type 2 diabetes mellitus, is an asymmetric Michael addition to give intermediate (IV).

SAR Development of Polycyclic Guanine De

SAR Development of Polycyclic Guanine Derivatives Targeted to the Discovery of a Selective PDE5 Inhibitor for Treatment of Erectile Dysfunction.

✍ Dmitri A. Pissarnitski; et al. et al. 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 69 KB 👁 2 views